Roche enlists digital transformation to improve patient outcomes

Roche enlists digital transformation to improve patient outcomes

Swiss multinational healthcare company, F. Hoffmann-La Roche AG, commonly known as Roche, has announced the introduction of the Roche Digital Pathology Open Environment that allows software developers to easily integrate their image analysis tools for tumour tissue with Roche’s uPath enterprise software, an application for pathologist workflow.

F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company that operates worldwide under two divisions: pharmaceuticals and diagnostics.

According to a Press release posted on its website on Wednesday, this open environment allows for the secure exchange and flow of data so that pathologists can access advanced algorithms from third parties alongside Roche’s menu of artificial intelligence-based image analysis tools.

“This enables software developers globally to distribute their digital products through Roche’s uPath software, offering a broader set of diagnostic tools for pathologists and, ultimately, the potential for better and faster answers for patients,” the statement declares.

It noted that, as artificial intelligence tools proposed for clinical use continue to develop, industry and research partners may leverage Roche’s Open Environment.

“This access expands the ability for pathologists to more easily read images generated from the VENTANA DP 200 slide scanner, which is needed for image analysis algorithm development.

“This also allows for partnerships between researchers and developers, which can result in greater access to innovative imaging tools for laboratories and healthcare providers for both research and clinical use,” it added.

It quoted the CEO Roche Diagnostics, Thomas Schinecker, as saying that Roche is at the centre of digital transformation for pathology, and is investing heavily in this innovation to improve patient outcomes.

“Providing pathologists with access to innovative digital tools from Roche and our collaborators through an open environment is critical for laboratory customers and the patients they serve,” Schinecker added.


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *